| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein Kinase Inhibitors | 36 | 2024 | 5672 | 2.630 |
Why?
|
| Models, Molecular | 67 | 2024 | 5439 | 2.410 |
Why?
|
| Crystallography, X-Ray | 44 | 2024 | 1990 | 2.260 |
Why?
|
| Protein Conformation | 42 | 2021 | 3968 | 1.860 |
Why?
|
| Proto-Oncogene Proteins B-raf | 5 | 2023 | 2057 | 1.620 |
Why?
|
| Microfilament Proteins | 8 | 2017 | 1134 | 1.420 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 8 | 2014 | 186 | 1.390 |
Why?
|
| ras Proteins | 4 | 2024 | 1054 | 1.370 |
Why?
|
| Protein Structure, Tertiary | 35 | 2014 | 3792 | 1.330 |
Why?
|
| src Homology Domains | 18 | 2016 | 361 | 1.140 |
Why?
|
| Janus Kinase 2 | 6 | 2019 | 560 | 1.120 |
Why?
|
| Actins | 8 | 2017 | 2050 | 1.080 |
Why?
|
| Drug Resistance, Neoplasm | 18 | 2024 | 5305 | 1.080 |
Why?
|
| Mutation | 41 | 2024 | 30054 | 1.050 |
Why?
|
| Lung Neoplasms | 27 | 2024 | 13382 | 1.010 |
Why?
|
| Adenosine Triphosphate | 10 | 2024 | 1989 | 0.980 |
Why?
|
| raf Kinases | 2 | 2024 | 118 | 0.960 |
Why?
|
| Amino Acid Sequence | 54 | 2017 | 13446 | 0.910 |
Why?
|
| Macrocyclic Compounds | 1 | 2024 | 68 | 0.910 |
Why?
|
| Binding Sites | 36 | 2024 | 6056 | 0.900 |
Why?
|
| 14-3-3 Proteins | 4 | 2024 | 220 | 0.890 |
Why?
|
| Protein Binding | 44 | 2020 | 9353 | 0.860 |
Why?
|
| Protein-Tyrosine Kinases | 17 | 2015 | 2425 | 0.830 |
Why?
|
| Exons | 6 | 2024 | 2391 | 0.810 |
Why?
|
| Molecular Sequence Data | 52 | 2015 | 17635 | 0.800 |
Why?
|
| Protein Structure, Secondary | 15 | 2020 | 1229 | 0.780 |
Why?
|
| Phosphorylation | 34 | 2022 | 8321 | 0.760 |
Why?
|
| MAP Kinase Signaling System | 4 | 2023 | 1486 | 0.750 |
Why?
|
| Benzeneacetamides | 2 | 2019 | 36 | 0.700 |
Why?
|
| src-Family Kinases | 12 | 2015 | 535 | 0.690 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2021 | 255 | 0.690 |
Why?
|
| Saccharomyces cerevisiae Proteins | 6 | 2015 | 1841 | 0.670 |
Why?
|
| Cryoelectron Microscopy | 2 | 2023 | 650 | 0.670 |
Why?
|
| Adaptor Proteins, Signal Transducing | 8 | 2017 | 2898 | 0.660 |
Why?
|
| Signal Transduction | 35 | 2024 | 23447 | 0.650 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 14 | 2024 | 5315 | 0.630 |
Why?
|
| Antineoplastic Agents | 22 | 2024 | 13642 | 0.610 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2019 | 332 | 0.590 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 6 | 2021 | 1626 | 0.580 |
Why?
|
| Mutant Proteins | 3 | 2016 | 491 | 0.580 |
Why?
|
| Imidazoles | 2 | 2021 | 1180 | 0.580 |
Why?
|
| Quinazolines | 12 | 2022 | 1371 | 0.560 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 12 | 2022 | 2872 | 0.560 |
Why?
|
| Carrier Proteins | 10 | 2014 | 4937 | 0.550 |
Why?
|
| Protein Multimerization | 8 | 2019 | 983 | 0.540 |
Why?
|
| Dimerization | 13 | 2013 | 891 | 0.540 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2023 | 1745 | 0.520 |
Why?
|
| Molecular Structure | 8 | 2024 | 1880 | 0.490 |
Why?
|
| Drug Design | 5 | 2021 | 1048 | 0.490 |
Why?
|
| Sequence Homology, Amino Acid | 14 | 2012 | 2748 | 0.480 |
Why?
|
| TYK2 Kinase | 2 | 2014 | 38 | 0.470 |
Why?
|
| Immunoglobulins | 6 | 2004 | 852 | 0.470 |
Why?
|
| Allosteric Regulation | 7 | 2021 | 426 | 0.440 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 934 | 0.440 |
Why?
|
| Enzyme Activation | 13 | 2021 | 3597 | 0.430 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 5 | 1999 | 145 | 0.430 |
Why?
|
| Thiazoles | 3 | 2019 | 1517 | 0.430 |
Why?
|
| Cell Proliferation | 11 | 2019 | 10448 | 0.420 |
Why?
|
| Mutagenesis, Insertional | 4 | 2024 | 656 | 0.420 |
Why?
|
| Sequence Alignment | 13 | 2016 | 2180 | 0.410 |
Why?
|
| Janus Kinases | 1 | 2013 | 248 | 0.400 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2015 | 1974 | 0.390 |
Why?
|
| Oogenesis | 1 | 2011 | 124 | 0.360 |
Why?
|
| Pyrimidines | 7 | 2024 | 3028 | 0.360 |
Why?
|
| rho GTP-Binding Proteins | 3 | 2007 | 276 | 0.360 |
Why?
|
| Glycoproteins | 7 | 2004 | 2203 | 0.350 |
Why?
|
| Staurosporine | 3 | 2007 | 242 | 0.350 |
Why?
|
| Protein Tyrosine Phosphatases | 5 | 2021 | 457 | 0.340 |
Why?
|
| Trans-Activators | 5 | 2004 | 2856 | 0.340 |
Why?
|
| Phosphatidylinositols | 2 | 2008 | 282 | 0.340 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2013 | 437 | 0.340 |
Why?
|
| Interferon-alpha | 1 | 2014 | 921 | 0.340 |
Why?
|
| Saccharomyces cerevisiae | 4 | 2015 | 2688 | 0.330 |
Why?
|
| rho-Associated Kinases | 1 | 2011 | 281 | 0.330 |
Why?
|
| Oncogenes | 2 | 2022 | 1222 | 0.330 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 5 | 2003 | 93 | 0.330 |
Why?
|
| Animals | 67 | 2024 | 168467 | 0.320 |
Why?
|
| Cell Line, Tumor | 25 | 2023 | 16986 | 0.320 |
Why?
|
| Structure-Activity Relationship | 9 | 2024 | 3076 | 0.320 |
Why?
|
| Nuclear Proteins | 6 | 2021 | 5799 | 0.320 |
Why?
|
| Proto-Oncogene Proteins | 11 | 2005 | 4513 | 0.310 |
Why?
|
| Protein Isoforms | 6 | 2023 | 1699 | 0.310 |
Why?
|
| Molecular Targeted Therapy | 2 | 2019 | 2811 | 0.310 |
Why?
|
| Ubiquitination | 1 | 2013 | 1007 | 0.300 |
Why?
|
| Protein Structure, Quaternary | 3 | 2004 | 429 | 0.300 |
Why?
|
| Acrylamides | 3 | 2021 | 260 | 0.290 |
Why?
|
| Cytoskeletal Proteins | 3 | 2005 | 1342 | 0.290 |
Why?
|
| Phosphotyrosine | 6 | 2015 | 456 | 0.280 |
Why?
|
| Aniline Compounds | 3 | 2022 | 1069 | 0.280 |
Why?
|
| Tyrosine | 7 | 2011 | 1440 | 0.280 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2009 | 431 | 0.270 |
Why?
|
| Humans | 109 | 2024 | 761572 | 0.270 |
Why?
|
| Focal Adhesions | 2 | 2011 | 115 | 0.270 |
Why?
|
| Fetal Proteins | 1 | 2007 | 98 | 0.270 |
Why?
|
| Macromolecular Substances | 6 | 2016 | 1434 | 0.270 |
Why?
|
| Drosophila Proteins | 3 | 2011 | 1699 | 0.260 |
Why?
|
| Phosphoproteins | 6 | 2000 | 2448 | 0.260 |
Why?
|
| Morpholines | 1 | 2008 | 581 | 0.250 |
Why?
|
| Lymphoproliferative Disorders | 4 | 2003 | 531 | 0.250 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 2803 | 0.250 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2009 | 423 | 0.240 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2021 | 1115 | 0.240 |
Why?
|
| Genetic Variation | 1 | 2020 | 6567 | 0.240 |
Why?
|
| Phosphopeptides | 5 | 1999 | 240 | 0.230 |
Why?
|
| Zinc | 3 | 2003 | 690 | 0.230 |
Why?
|
| Receptor, erbB-2 | 5 | 2022 | 2557 | 0.230 |
Why?
|
| Protein Interaction Domains and Motifs | 3 | 2015 | 452 | 0.220 |
Why?
|
| Prokaryotic Cells | 1 | 2003 | 51 | 0.220 |
Why?
|
| Amino Acid Motifs | 7 | 2010 | 931 | 0.210 |
Why?
|
| Adhesins, Bacterial | 1 | 2003 | 118 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2022 | 2456 | 0.210 |
Why?
|
| Transcription Factors | 8 | 2016 | 12129 | 0.200 |
Why?
|
| Neoplasms | 6 | 2024 | 22173 | 0.200 |
Why?
|
| HMGB Proteins | 1 | 2001 | 45 | 0.200 |
Why?
|
| Protein Phosphatase 1 | 1 | 2022 | 134 | 0.200 |
Why?
|
| Drug Resistance | 1 | 2008 | 1596 | 0.190 |
Why?
|
| Tryptophan | 2 | 2001 | 482 | 0.190 |
Why?
|
| Anthranilate Synthase | 1 | 2001 | 5 | 0.190 |
Why?
|
| Enzyme Stability | 1 | 2021 | 219 | 0.190 |
Why?
|
| Janus Kinase 3 | 2 | 2015 | 76 | 0.190 |
Why?
|
| Peptides | 7 | 2016 | 4358 | 0.180 |
Why?
|
| Mitosis | 3 | 2016 | 1188 | 0.180 |
Why?
|
| Allosteric Site | 2 | 2021 | 103 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 2 | 2011 | 4415 | 0.180 |
Why?
|
| Protein Kinases | 3 | 2024 | 1608 | 0.170 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 4948 | 0.170 |
Why?
|
| Substrate Specificity | 9 | 2015 | 1791 | 0.170 |
Why?
|
| Cloning, Molecular | 6 | 2015 | 4174 | 0.170 |
Why?
|
| Homeostasis | 1 | 2010 | 3323 | 0.160 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 2 | 2017 | 77 | 0.160 |
Why?
|
| NIH 3T3 Cells | 7 | 2019 | 670 | 0.160 |
Why?
|
| Dystrophin | 1 | 2000 | 283 | 0.160 |
Why?
|
| Genes, erbB-1 | 2 | 2013 | 162 | 0.160 |
Why?
|
| Clathrin | 1 | 2020 | 257 | 0.160 |
Why?
|
| Adenosine Triphosphatases | 1 | 2003 | 836 | 0.160 |
Why?
|
| Mice | 31 | 2023 | 81533 | 0.160 |
Why?
|
| Receptors, Cell Surface | 8 | 2004 | 2822 | 0.160 |
Why?
|
| Salmonella typhimurium | 1 | 2001 | 347 | 0.160 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2020 | 305 | 0.160 |
Why?
|
| Ubiquitin-Protein Ligases | 4 | 2010 | 1899 | 0.150 |
Why?
|
| Pyrazoles | 3 | 2016 | 2009 | 0.150 |
Why?
|
| Foodborne Diseases | 1 | 2018 | 41 | 0.150 |
Why?
|
| Serine Endopeptidases | 1 | 2003 | 1023 | 0.150 |
Why?
|
| Gene Expression | 6 | 2017 | 7581 | 0.150 |
Why?
|
| Multiprotein Complexes | 2 | 2022 | 1120 | 0.150 |
Why?
|
| Food Analysis | 1 | 2018 | 103 | 0.150 |
Why?
|
| Salmonella | 1 | 2018 | 125 | 0.150 |
Why?
|
| Static Electricity | 2 | 2012 | 261 | 0.150 |
Why?
|
| Cytokinesis | 2 | 2010 | 171 | 0.150 |
Why?
|
| Receptors, Mitogen | 2 | 2011 | 61 | 0.140 |
Why?
|
| Birds | 2 | 2008 | 168 | 0.140 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 3 | 2014 | 124 | 0.140 |
Why?
|
| GTPase-Activating Proteins | 1 | 2020 | 471 | 0.140 |
Why?
|
| Fluorescence Polarization | 2 | 2021 | 140 | 0.140 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2023 | 2827 | 0.140 |
Why?
|
| Salmonella Infections | 1 | 2018 | 172 | 0.140 |
Why?
|
| Acoustics | 1 | 2018 | 242 | 0.140 |
Why?
|
| Fluorobenzenes | 1 | 2018 | 179 | 0.140 |
Why?
|
| Enzyme Inhibitors | 6 | 2012 | 3713 | 0.140 |
Why?
|
| Mutagenesis, Site-Directed | 5 | 2017 | 1693 | 0.130 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2016 | 85 | 0.130 |
Why?
|
| Molecular Conformation | 3 | 2017 | 544 | 0.130 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2015 | 46 | 0.130 |
Why?
|
| Hedgehog Proteins | 1 | 2021 | 768 | 0.130 |
Why?
|
| Escherichia coli | 9 | 2015 | 4217 | 0.130 |
Why?
|
| Antigens, CD | 7 | 2004 | 4001 | 0.130 |
Why?
|
| Adenocarcinoma | 5 | 2014 | 6346 | 0.130 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2003 | 2547 | 0.130 |
Why?
|
| Benzamides | 2 | 2014 | 1370 | 0.130 |
Why?
|
| Recombinant Proteins | 6 | 2015 | 6534 | 0.130 |
Why?
|
| Drug Discovery | 2 | 2021 | 1051 | 0.130 |
Why?
|
| Cell Line | 10 | 2019 | 15601 | 0.130 |
Why?
|
| Lymphocyte Activation | 2 | 2003 | 5485 | 0.130 |
Why?
|
| Cell Division | 3 | 2021 | 4465 | 0.120 |
Why?
|
| Ligands | 3 | 2019 | 3272 | 0.120 |
Why?
|
| Rabbits | 2 | 2015 | 4772 | 0.120 |
Why?
|
| Cell Membrane | 2 | 2023 | 3687 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2024 | 10766 | 0.120 |
Why?
|
| Hydrogen Bonding | 5 | 2012 | 291 | 0.120 |
Why?
|
| Milk | 1 | 2018 | 443 | 0.120 |
Why?
|
| Drug Resistance, Multiple | 1 | 2016 | 255 | 0.120 |
Why?
|
| Drug Synergism | 2 | 2016 | 1756 | 0.120 |
Why?
|
| Calorimetry | 2 | 2006 | 129 | 0.120 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2012 | 3733 | 0.120 |
Why?
|
| Amino Acid Substitution | 6 | 2017 | 1739 | 0.120 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2017 | 380 | 0.120 |
Why?
|
| Conserved Sequence | 3 | 2016 | 1163 | 0.120 |
Why?
|
| Quinolines | 3 | 2016 | 764 | 0.120 |
Why?
|
| Neurogenesis | 1 | 2021 | 863 | 0.120 |
Why?
|
| Crystallization | 2 | 2013 | 534 | 0.110 |
Why?
|
| Thermodynamics | 1 | 2015 | 595 | 0.110 |
Why?
|
| Publications | 1 | 2016 | 194 | 0.110 |
Why?
|
| Cytoplasm | 3 | 2010 | 1510 | 0.110 |
Why?
|
| Cerebellum | 1 | 2021 | 1501 | 0.110 |
Why?
|
| Proteins | 5 | 2016 | 6032 | 0.110 |
Why?
|
| Neural Stem Cells | 1 | 2021 | 888 | 0.110 |
Why?
|
| Biosensing Techniques | 2 | 2018 | 650 | 0.110 |
Why?
|
| Point Mutation | 6 | 2011 | 1595 | 0.110 |
Why?
|
| Cell Adhesion | 3 | 2014 | 3088 | 0.110 |
Why?
|
| Autocrine Communication | 1 | 2014 | 169 | 0.110 |
Why?
|
| T-Lymphocytes | 4 | 2004 | 10194 | 0.110 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2016 | 1188 | 0.100 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2014 | 426 | 0.100 |
Why?
|
| Binding, Competitive | 2 | 2012 | 1141 | 0.100 |
Why?
|
| Membrane Glycoproteins | 2 | 2000 | 3701 | 0.100 |
Why?
|
| Receptor, Insulin | 1 | 1996 | 836 | 0.100 |
Why?
|
| Repressor Proteins | 1 | 2003 | 2986 | 0.100 |
Why?
|
| Structural Homology, Protein | 2 | 2013 | 87 | 0.100 |
Why?
|
| Resorcinols | 1 | 2012 | 41 | 0.100 |
Why?
|
| Cell Polarity | 2 | 2007 | 636 | 0.100 |
Why?
|
| Muscle Proteins | 1 | 2017 | 1154 | 0.100 |
Why?
|
| Protein Subunits | 3 | 2022 | 943 | 0.100 |
Why?
|
| Models, Chemical | 3 | 2009 | 611 | 0.100 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2013 | 141 | 0.100 |
Why?
|
| Drosophila melanogaster | 2 | 2011 | 1712 | 0.100 |
Why?
|
| Cell Survival | 5 | 2019 | 5791 | 0.100 |
Why?
|
| I-kappa B Kinase | 1 | 2013 | 250 | 0.100 |
Why?
|
| Leukemia, B-Cell | 1 | 2012 | 84 | 0.100 |
Why?
|
| Aminopyridines | 1 | 2015 | 573 | 0.090 |
Why?
|
| DNA-Binding Proteins | 4 | 2014 | 9610 | 0.090 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2011 | 162 | 0.090 |
Why?
|
| Schiff Bases | 1 | 2010 | 22 | 0.090 |
Why?
|
| Cyclic GMP | 1 | 2012 | 395 | 0.090 |
Why?
|
| Tropomyosin | 1 | 2011 | 104 | 0.090 |
Why?
|
| Mutation, Missense | 5 | 2013 | 2571 | 0.090 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2004 | 619 | 0.090 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2003 | 509 | 0.090 |
Why?
|
| Peptide Library | 4 | 2016 | 347 | 0.090 |
Why?
|
| Isoxazoles | 1 | 2012 | 232 | 0.090 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 2010 | 67 | 0.090 |
Why?
|
| Retroviridae | 2 | 2012 | 850 | 0.090 |
Why?
|
| Benzimidazoles | 1 | 2015 | 858 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 1994 | 4352 | 0.090 |
Why?
|
| Crystallography | 3 | 2005 | 116 | 0.080 |
Why?
|
| Lunate Bone | 1 | 2009 | 38 | 0.080 |
Why?
|
| Profilins | 2 | 2007 | 65 | 0.080 |
Why?
|
| Triangular Fibrocartilage | 1 | 2009 | 27 | 0.080 |
Why?
|
| Cell Physiological Phenomena | 1 | 2010 | 150 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 3 | 2004 | 110 | 0.080 |
Why?
|
| Protein Biosynthesis | 1 | 2016 | 2112 | 0.080 |
Why?
|
| Databases, Genetic | 1 | 2016 | 1742 | 0.080 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2012 | 424 | 0.080 |
Why?
|
| Models, Anatomic | 1 | 2012 | 683 | 0.080 |
Why?
|
| Protein Folding | 2 | 2003 | 870 | 0.080 |
Why?
|
| Scaphoid Bone | 1 | 2009 | 85 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2019 | 3603 | 0.080 |
Why?
|
| Genes, Reporter | 2 | 2003 | 1529 | 0.080 |
Why?
|
| Cell Cycle Proteins | 3 | 2010 | 3449 | 0.080 |
Why?
|
| Proteomics | 2 | 2023 | 3848 | 0.070 |
Why?
|
| BRCA1 Protein | 1 | 2014 | 1158 | 0.070 |
Why?
|
| Two-Hybrid System Techniques | 3 | 2004 | 460 | 0.070 |
Why?
|
| Dexamethasone | 1 | 2015 | 1948 | 0.070 |
Why?
|
| Gene Deletion | 1 | 2015 | 2665 | 0.070 |
Why?
|
| Cadherins | 2 | 2003 | 903 | 0.070 |
Why?
|
| Catalytic Domain | 1 | 2009 | 705 | 0.070 |
Why?
|
| Cell Movement | 3 | 2012 | 5205 | 0.070 |
Why?
|
| Integrins | 2 | 2020 | 834 | 0.070 |
Why?
|
| Affinity Labels | 1 | 2007 | 107 | 0.070 |
Why?
|
| Membrane Proteins | 4 | 2012 | 7858 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2023 | 3816 | 0.070 |
Why?
|
| Leukemia | 1 | 2015 | 1522 | 0.070 |
Why?
|
| Wrist Injuries | 1 | 2009 | 214 | 0.070 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2010 | 398 | 0.070 |
Why?
|
| Circular Dichroism | 3 | 2003 | 344 | 0.070 |
Why?
|
| Ligaments, Articular | 1 | 2009 | 302 | 0.070 |
Why?
|
| Bronchial Neoplasms | 1 | 2007 | 110 | 0.070 |
Why?
|
| HeLa Cells | 3 | 2020 | 3094 | 0.070 |
Why?
|
| Proline | 2 | 2000 | 457 | 0.070 |
Why?
|
| SH2 Domain-Containing Protein Tyrosine Phosphatases | 4 | 2001 | 43 | 0.070 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 1551 | 0.070 |
Why?
|
| Cell Nucleus | 2 | 2016 | 2910 | 0.070 |
Why?
|
| Lymphoma | 1 | 2015 | 1901 | 0.070 |
Why?
|
| Neuropeptides | 1 | 2011 | 944 | 0.070 |
Why?
|
| Blood Proteins | 2 | 2005 | 1173 | 0.060 |
Why?
|
| Peptide Fragments | 7 | 2014 | 5112 | 0.060 |
Why?
|
| Transduction, Genetic | 1 | 2008 | 903 | 0.060 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 4 | 2001 | 120 | 0.060 |
Why?
|
| Myeloproliferative Disorders | 1 | 2012 | 613 | 0.060 |
Why?
|
| Hydatidiform Mole, Invasive | 1 | 2005 | 4 | 0.060 |
Why?
|
| Glycine | 1 | 2008 | 663 | 0.060 |
Why?
|
| DNA Repair | 1 | 2014 | 2046 | 0.060 |
Why?
|
| Immunoblotting | 3 | 2013 | 1646 | 0.060 |
Why?
|
| Receptors, Immunologic | 2 | 2003 | 1410 | 0.060 |
Why?
|
| Oligopeptides | 1 | 2010 | 1187 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 3 | 2000 | 120 | 0.060 |
Why?
|
| Repetitive Sequences, Amino Acid | 2 | 2001 | 92 | 0.060 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 4 | 2001 | 223 | 0.060 |
Why?
|
| Melanoma | 1 | 2023 | 5709 | 0.060 |
Why?
|
| Codon | 2 | 2017 | 601 | 0.060 |
Why?
|
| Vaginal Neoplasms | 1 | 2005 | 104 | 0.060 |
Why?
|
| Transfection | 4 | 2011 | 5774 | 0.060 |
Why?
|
| Thrombocythemia, Essential | 1 | 2005 | 113 | 0.060 |
Why?
|
| Radius Fractures | 1 | 2009 | 515 | 0.060 |
Why?
|
| Purines | 1 | 2007 | 607 | 0.050 |
Why?
|
| X-Ray Diffraction | 3 | 2001 | 421 | 0.050 |
Why?
|
| Polycythemia Vera | 1 | 2005 | 161 | 0.050 |
Why?
|
| Endopeptidase Clp | 1 | 2003 | 42 | 0.050 |
Why?
|
| HEK293 Cells | 3 | 2020 | 4280 | 0.050 |
Why?
|
| Sequence Analysis, Protein | 1 | 2004 | 261 | 0.050 |
Why?
|
| Chickens | 1 | 2005 | 859 | 0.050 |
Why?
|
| Qc-SNARE Proteins | 1 | 2003 | 20 | 0.050 |
Why?
|
| Qb-SNARE Proteins | 1 | 2003 | 34 | 0.050 |
Why?
|
| Phosphoserine | 1 | 2003 | 203 | 0.050 |
Why?
|
| Aminopeptidases | 1 | 2003 | 95 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 2065 | 0.050 |
Why?
|
| Primary Myelofibrosis | 1 | 2005 | 209 | 0.050 |
Why?
|
| Morphogenesis | 1 | 2007 | 741 | 0.050 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 2014 | 435 | 0.050 |
Why?
|
| Gene Knockout Techniques | 2 | 2017 | 802 | 0.050 |
Why?
|
| Arthroscopy | 1 | 2009 | 969 | 0.050 |
Why?
|
| Endocytosis | 1 | 2007 | 957 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 18253 | 0.050 |
Why?
|
| Insulin | 1 | 2017 | 6597 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2008 | 14416 | 0.050 |
Why?
|
| Transcription Factor 7-Like 1 Protein | 1 | 2001 | 23 | 0.050 |
Why?
|
| Asparagine | 1 | 2002 | 119 | 0.050 |
Why?
|
| Ciona intestinalis | 1 | 2021 | 10 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2014 | 3677 | 0.050 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2004 | 220 | 0.050 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 2 | 1999 | 69 | 0.050 |
Why?
|
| Kinetics | 2 | 2008 | 6374 | 0.050 |
Why?
|
| Guanosine Triphosphate | 1 | 2022 | 316 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2021 | 3769 | 0.050 |
Why?
|
| Sulfolobus | 1 | 2001 | 5 | 0.050 |
Why?
|
| Azepines | 1 | 2003 | 329 | 0.050 |
Why?
|
| Dipeptides | 1 | 2003 | 391 | 0.050 |
Why?
|
| TCF Transcription Factors | 1 | 2001 | 138 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 2 | 2017 | 1612 | 0.050 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2001 | 152 | 0.050 |
Why?
|
| Microtubules | 1 | 2007 | 1074 | 0.050 |
Why?
|
| EF Hand Motifs | 1 | 2000 | 14 | 0.050 |
Why?
|
| Amino Acids | 3 | 2014 | 1718 | 0.050 |
Why?
|
| Dystroglycans | 1 | 2000 | 62 | 0.050 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 2000 | 74 | 0.040 |
Why?
|
| Epitope Mapping | 1 | 2001 | 298 | 0.040 |
Why?
|
| Genes, ras | 1 | 2023 | 654 | 0.040 |
Why?
|
| Quinazolinones | 1 | 2022 | 221 | 0.040 |
Why?
|
| Glioma | 1 | 2015 | 3455 | 0.040 |
Why?
|
| Breast Neoplasms | 3 | 2017 | 21017 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2012 | 3066 | 0.040 |
Why?
|
| Antigen-Presenting Cells | 1 | 2003 | 964 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 1994 | 585 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2003 | 1126 | 0.040 |
Why?
|
| Receptors, Virus | 1 | 2003 | 640 | 0.040 |
Why?
|
| Blood Coagulation Factors | 1 | 2001 | 365 | 0.040 |
Why?
|
| Disulfides | 2 | 2004 | 465 | 0.040 |
Why?
|
| Ligases | 1 | 2000 | 333 | 0.040 |
Why?
|
| Mice, Nude | 3 | 2012 | 3614 | 0.040 |
Why?
|
| Xenopus Proteins | 1 | 2001 | 434 | 0.040 |
Why?
|
| Receptors, Transferrin | 1 | 2020 | 291 | 0.040 |
Why?
|
| Pyridines | 1 | 2010 | 2875 | 0.040 |
Why?
|
| Receptors, LDL | 1 | 2001 | 488 | 0.040 |
Why?
|
| Epidermal Growth Factor | 1 | 2001 | 702 | 0.040 |
Why?
|
| Piperazines | 1 | 2009 | 2523 | 0.040 |
Why?
|
| RNA, Small Interfering | 3 | 2016 | 3430 | 0.040 |
Why?
|
| Phenols | 1 | 2022 | 517 | 0.040 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 1999 | 557 | 0.040 |
Why?
|
| Food Microbiology | 1 | 2018 | 74 | 0.040 |
Why?
|
| Protein Engineering | 1 | 2002 | 549 | 0.040 |
Why?
|
| Models, Biological | 4 | 2014 | 9469 | 0.040 |
Why?
|
| Thymus Gland | 1 | 2003 | 1243 | 0.040 |
Why?
|
| Cells, Cultured | 5 | 2013 | 18965 | 0.040 |
Why?
|
| DNA Primers | 2 | 2012 | 2819 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2021 | 1749 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2018 | 273 | 0.040 |
Why?
|
| Sequence Deletion | 3 | 2011 | 1494 | 0.040 |
Why?
|
| Computer Graphics | 2 | 2001 | 340 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2007 | 3442 | 0.040 |
Why?
|
| Lipoproteins, VLDL | 1 | 1997 | 201 | 0.030 |
Why?
|
| Luciferases | 2 | 2012 | 714 | 0.030 |
Why?
|
| Food Contamination | 1 | 2018 | 191 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 2 | 2016 | 517 | 0.030 |
Why?
|
| beta Catenin | 1 | 2001 | 1040 | 0.030 |
Why?
|
| Interleukin-6 | 2 | 2014 | 3208 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2019 | 11742 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 4575 | 0.030 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2001 | 395 | 0.030 |
Why?
|
| Peptide Mapping | 1 | 1996 | 262 | 0.030 |
Why?
|
| Sound | 1 | 2018 | 257 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2002 | 1756 | 0.030 |
Why?
|
| Cell Communication | 1 | 2003 | 1657 | 0.030 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2015 | 101 | 0.030 |
Why?
|
| Uterine Neoplasms | 1 | 2005 | 1420 | 0.030 |
Why?
|
| Leucine | 1 | 2017 | 548 | 0.030 |
Why?
|
| Phenylalanine | 1 | 2017 | 366 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2015 | 200 | 0.030 |
Why?
|
| Gallamine Triethiodide | 1 | 1994 | 4 | 0.030 |
Why?
|
| Biological Availability | 1 | 2015 | 390 | 0.030 |
Why?
|
| DNA, Neoplasm | 2 | 2013 | 1745 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2015 | 465 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 6935 | 0.030 |
Why?
|
| Histone Chaperones | 1 | 2014 | 84 | 0.030 |
Why?
|
| Lymphotoxin-alpha | 2 | 1994 | 93 | 0.030 |
Why?
|
| Biocatalysis | 1 | 2014 | 170 | 0.030 |
Why?
|
| Protein Interaction Mapping | 2 | 2010 | 616 | 0.030 |
Why?
|
| Receptors, Muscarinic | 1 | 1994 | 157 | 0.030 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2018 | 432 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2003 | 6075 | 0.030 |
Why?
|
| Chemokine CCL5 | 1 | 2014 | 214 | 0.030 |
Why?
|
| I-kappa B Proteins | 1 | 2014 | 211 | 0.030 |
Why?
|
| Collagen | 1 | 2001 | 2638 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2018 | 1479 | 0.030 |
Why?
|
| Glycolysis | 1 | 2017 | 835 | 0.030 |
Why?
|
| Protein Stability | 1 | 2014 | 578 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2014 | 441 | 0.030 |
Why?
|
| Fungal Proteins | 1 | 1996 | 910 | 0.030 |
Why?
|
| Molecular Weight | 2 | 1996 | 2186 | 0.020 |
Why?
|
| Immunohistochemistry | 3 | 2012 | 11076 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2012 | 129 | 0.020 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2016 | 569 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 1997 | 1444 | 0.020 |
Why?
|
| Hormones | 1 | 2016 | 869 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2014 | 421 | 0.020 |
Why?
|
| Arginine | 2 | 2010 | 934 | 0.020 |
Why?
|
| Transplantation, Heterologous | 2 | 2014 | 2385 | 0.020 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1993 | 340 | 0.020 |
Why?
|
| Receptors, Cytokine | 1 | 2012 | 258 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 878 | 0.020 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2011 | 187 | 0.020 |
Why?
|
| Adenine | 1 | 2016 | 987 | 0.020 |
Why?
|
| Isoleucine | 1 | 2010 | 110 | 0.020 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2011 | 242 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 7593 | 0.020 |
Why?
|
| Indazoles | 1 | 2012 | 304 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2014 | 709 | 0.020 |
Why?
|
| Base Sequence | 3 | 2013 | 12441 | 0.020 |
Why?
|
| Equipment Design | 1 | 2018 | 3511 | 0.020 |
Why?
|
| Triglycerides | 1 | 1997 | 2461 | 0.020 |
Why?
|
| Apoptosis | 2 | 2016 | 9489 | 0.020 |
Why?
|
| Histidine | 1 | 2010 | 308 | 0.020 |
Why?
|
| COS Cells | 2 | 2001 | 1130 | 0.020 |
Why?
|
| X-Ray Microtomography | 1 | 2012 | 456 | 0.020 |
Why?
|
| Arthrography | 1 | 2009 | 150 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2014 | 1229 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1989 | 1058 | 0.020 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2004 | 3615 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2012 | 2016 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2001 | 4758 | 0.020 |
Why?
|
| Zinc Fingers | 1 | 2010 | 579 | 0.020 |
Why?
|
| Piperidines | 1 | 2016 | 1656 | 0.020 |
Why?
|
| Rupture | 1 | 2009 | 443 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2012 | 1232 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 14666 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2014 | 2707 | 0.020 |
Why?
|
| Acids | 1 | 2007 | 125 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2014 | 9420 | 0.020 |
Why?
|
| Capsid | 1 | 1989 | 435 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2015 | 2932 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2014 | 1616 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2003 | 22172 | 0.020 |
Why?
|
| Female | 12 | 2017 | 392686 | 0.020 |
Why?
|
| Macrophages | 1 | 2001 | 5769 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 9541 | 0.020 |
Why?
|
| Bone Plates | 1 | 2009 | 466 | 0.020 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2006 | 84 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2007 | 613 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2007 | 614 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2012 | 1893 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2010 | 1687 | 0.020 |
Why?
|
| Lysine | 1 | 2010 | 993 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2004 | 7407 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2010 | 839 | 0.020 |
Why?
|
| Male | 11 | 2017 | 360842 | 0.020 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2010 | 727 | 0.020 |
Why?
|
| Models, Structural | 1 | 2005 | 340 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2010 | 1393 | 0.010 |
Why?
|
| Indole Alkaloids | 1 | 2004 | 23 | 0.010 |
Why?
|
| DNA Damage | 1 | 2014 | 2449 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2009 | 1334 | 0.010 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2004 | 37 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2010 | 2510 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 2645 | 0.010 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2004 | 87 | 0.010 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2004 | 120 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1996 | 1741 | 0.010 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2004 | 123 | 0.010 |
Why?
|
| Phospholipids | 1 | 2007 | 786 | 0.010 |
Why?
|
| Internet | 1 | 2016 | 3093 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2003 | 283 | 0.010 |
Why?
|
| Cobalt | 1 | 2003 | 154 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-yes | 1 | 2003 | 15 | 0.010 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2004 | 186 | 0.010 |
Why?
|
| Cyclohexanes | 1 | 2003 | 152 | 0.010 |
Why?
|
| Granulocytes | 1 | 2005 | 551 | 0.010 |
Why?
|
| Interleukin-3 | 1 | 2004 | 425 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 698 | 0.010 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 11904 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2012 | 6214 | 0.010 |
Why?
|
| Fracture Fixation, Internal | 1 | 2009 | 973 | 0.010 |
Why?
|
| Sesquiterpenes | 1 | 2003 | 176 | 0.010 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2003 | 370 | 0.010 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2010 | 1609 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 2010 | 1250 | 0.010 |
Why?
|
| Mouth Mucosa | 1 | 2005 | 432 | 0.010 |
Why?
|
| Chick Embryo | 1 | 2004 | 982 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2012 | 1978 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 2005 | 750 | 0.010 |
Why?
|
| RNA Interference | 1 | 2010 | 2832 | 0.010 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2005 | 284 | 0.010 |
Why?
|
| Liver | 1 | 1997 | 7529 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 2004 | 656 | 0.010 |
Why?
|
| Software | 1 | 2016 | 4434 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2003 | 506 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 3639 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2004 | 1762 | 0.010 |
Why?
|
| Dictyostelium | 1 | 2001 | 70 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2012 | 5869 | 0.010 |
Why?
|
| Alleles | 1 | 2012 | 6864 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2011 | 4141 | 0.010 |
Why?
|
| Stem Cells | 1 | 2014 | 3523 | 0.010 |
Why?
|
| Oncogene Protein v-cbl | 1 | 2000 | 11 | 0.010 |
Why?
|
| Adult | 6 | 2017 | 221203 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2001 | 813 | 0.010 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2004 | 495 | 0.010 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2003 | 540 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 20571 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2005 | 1519 | 0.010 |
Why?
|
| Homozygote | 1 | 2005 | 1776 | 0.010 |
Why?
|
| Sirolimus | 1 | 2007 | 1533 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2001 | 740 | 0.010 |
Why?
|
| Japan | 1 | 2004 | 1378 | 0.010 |
Why?
|
| Wiskott-Aldrich Syndrome Protein | 1 | 2000 | 161 | 0.010 |
Why?
|
| Erythropoietin | 1 | 2004 | 719 | 0.010 |
Why?
|
| p21-Activated Kinases | 1 | 2000 | 128 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2004 | 2297 | 0.010 |
Why?
|
| Middle Aged | 5 | 2017 | 220920 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2017 | 64684 | 0.010 |
Why?
|
| Cytokine Receptor gp130 | 1 | 1998 | 66 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2011 | 3548 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2003 | 1170 | 0.010 |
Why?
|
| Janus Kinase 1 | 1 | 1998 | 107 | 0.010 |
Why?
|
| Glycosylation | 1 | 2001 | 1097 | 0.010 |
Why?
|
| Heterozygote | 1 | 2005 | 2787 | 0.010 |
Why?
|
| Methotrexate | 1 | 2005 | 1719 | 0.010 |
Why?
|
| Aged | 5 | 2011 | 169310 | 0.010 |
Why?
|
| Receptors, Interleukin-6 | 1 | 1998 | 225 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 2009 | 58986 | 0.010 |
Why?
|
| Sequence Analysis, RNA | 1 | 2005 | 2020 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1996 | 201 | 0.010 |
Why?
|
| Plasmids | 1 | 2001 | 2269 | 0.010 |
Why?
|
| Trypsin | 1 | 1996 | 495 | 0.010 |
Why?
|
| Liver Neoplasms | 2 | 2004 | 4319 | 0.010 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 1996 | 178 | 0.010 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 1996 | 163 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1996 | 645 | 0.010 |
Why?
|
| N-Methylscopolamine | 1 | 1994 | 4 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1996 | 783 | 0.010 |
Why?
|
| Scopolamine Derivatives | 1 | 1994 | 24 | 0.010 |
Why?
|
| STAT3 Transcription Factor | 1 | 1998 | 871 | 0.010 |
Why?
|
| Magnesium | 1 | 1998 | 804 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2005 | 4740 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2001 | 5035 | 0.010 |
Why?
|
| Methionine | 1 | 1996 | 572 | 0.010 |
Why?
|
| Muscarinic Antagonists | 1 | 1994 | 135 | 0.010 |
Why?
|
| Proteome | 1 | 2003 | 1862 | 0.010 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2003 | 2047 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2004 | 3492 | 0.010 |
Why?
|
| Catalysis | 1 | 1995 | 774 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 1995 | 225 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 1996 | 687 | 0.010 |
Why?
|
| Biopsy | 1 | 2005 | 6766 | 0.010 |
Why?
|
| Perfusion | 1 | 1997 | 1373 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 9002 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2004 | 2538 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1994 | 779 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 1996 | 727 | 0.010 |
Why?
|
| Leukocytes | 1 | 1999 | 2026 | 0.010 |
Why?
|
| Lung | 1 | 2009 | 10002 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1998 | 6132 | 0.010 |
Why?
|
| Genotype | 1 | 2005 | 12990 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 1997 | 2693 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1994 | 2496 | 0.010 |
Why?
|
| Rats | 1 | 2004 | 23741 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2005 | 9280 | 0.000 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 1996 | 2865 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2009 | 54426 | 0.000 |
Why?
|
| Phenotype | 1 | 2001 | 16592 | 0.000 |
Why?
|
| Pregnancy | 1 | 2005 | 29876 | 0.000 |
Why?
|
| Young Adult | 1 | 2009 | 59255 | 0.000 |
Why?
|
| Prostatic Neoplasms | 1 | 2004 | 11122 | 0.000 |
Why?
|
| Adolescent | 1 | 2009 | 88324 | 0.000 |
Why?
|
| United States | 1 | 2004 | 72335 | 0.000 |
Why?
|